Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
-
Authors :
Onoda N; Prospective Clinical Study Committee of Anaplastic Thyroid Carcinoma Research Consortium of Japan, Headquarter in the Department of Endocrine Surgery, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan. .; Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan. .
Subjects: Treatment Outcome*; Paclitaxel/Paclitaxel/Paclitaxel/*administration & dosage ; Thyroid Carcinoma, Anaplastic/Thyroid Carcinoma, Anaplastic/Thyroid Carcinoma, Anaplastic/*drug therapy
-
Source:
BMC cancer [BMC Cancer] 2015 Jun 20; Vol. 15, pp. 475. Date of Electronic Publication: 2015 Jun 20.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407
Record details